Variant report
Variant | nsv10559 |
---|---|
Chromosome Location | chr4:122281398-122292297 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:231)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:122198899..122199696-chr4:122292166..122292719,2 | MCF-7 | breast: | |
2 | chr4:122265924..122266538-chr4:122292160..122292685,2 | MCF-7 | breast: | |
3 | chr4:122291624..122292430-chr4:122342879..122343479,3 | MCF-7 | breast: | |
4 | chr4:122291642..122292373-chr4:122577439..122577960,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TNIP3-2 | chr4:122290588-122291500 | NONHSAT098140 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213480 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12507798 | chr4:122281488-122281489 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs187530152 | chr4:122281534-122281535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561515472 | chr4:122281557-122281558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368783385 | chr4:122281567-122281568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs28716099 | chr4:122281621-122281622 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs546692996 | chr4:122281635-122281636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547159668 | chr4:122281669-122281670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567478770 | chr4:122281676-122281677 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543419009 | chr4:122281686-122281687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138300390 | chr4:122281730-122281731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556286229 | chr4:122281731-122281732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575937394 | chr4:122281732-122281733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538518541 | chr4:122281740-122281741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557747396 | chr4:122281843-122281844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577601463 | chr4:122281912-122281913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs41422451 | chr4:122281973-122281974 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs62319044 | chr4:122281991-122281992 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs574215339 | chr4:122282049-122282050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs369682457 | chr4:122282054-122282055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563023808 | chr4:122282064-122282065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16997669 | chr4:122282080-122282081 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs68079620 | chr4:122282161-122282162 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs564905987 | chr4:122282239-122282240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71602329 | chr4:122282248-122282249 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs547513986 | chr4:122282262-122282263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115259588 | chr4:122282263-122282264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143840665 | chr4:122282271-122282272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549733691 | chr4:122282272-122282273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569480971 | chr4:122282273-122282274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538583129 | chr4:122282297-122282298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71602330 | chr4:122282306-122282307 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs571353870 | chr4:122282369-122282370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533932892 | chr4:122282397-122282398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554094670 | chr4:122282409-122282410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574053687 | chr4:122282426-122282427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543079281 | chr4:122282473-122282474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192344414 | chr4:122282475-122282476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576692555 | chr4:122282483-122282484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545742398 | chr4:122282487-122282488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13122399 | chr4:122282512-122282513 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs147236036 | chr4:122282558-122282559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184142167 | chr4:122282570-122282571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139162474 | chr4:122282576-122282577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529769115 | chr4:122282577-122282578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549452560 | chr4:122282585-122282586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73845781 | chr4:122282590-122282591 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs114502637 | chr4:122282625-122282626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs143085924 | chr4:122282636-122282637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116514471 | chr4:122282650-122282651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74822219 | chr4:122282725-122282726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Clear cell renal cell carcinoma | 18791270 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Gastric cancer | 16891809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:122280200-122281400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:122280200-122281600 | Weak transcription | NHEK | skin |
3 | chr4:122280400-122281400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr4:122280400-122281400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:122280400-122281600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr4:122280400-122281600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
7 | chr4:122281000-122282200 | Enhancers | HMEC | breast |
8 | chr4:122281200-122282200 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
9 | chr4:122281200-122282200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr4:122281200-122283400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr4:122281400-122282200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr4:122281400-122282200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr4:122281600-122281800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr4:122281600-122282200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr4:122281600-122282200 | Enhancers | Muscle Satellite Cultured Cells | -- |
16 | chr4:122281600-122282200 | Enhancers | NHEK | skin |
17 | chr4:122282200-122294000 | Weak transcription | HMEC | breast |
18 | chr4:122282200-122295600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr4:122283400-122284000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr4:122287600-122288400 | Enhancers | Left Ventricle | heart |
21 | chr4:122290600-122290800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |